PROVIDER PROFILE · NPI 1033616669
Benjamin Yglesias
PRESCRIBING · PART D · 2024
Total Rx claims
13
Beneficiaries
—
Total drug cost
$103
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Ondansetron13 claims
QUALITY · MIPS · 2024
Final MIPS score
94.0
Quality
81.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.80%
APM Entity
CROSS-REFERENCE